Prognos Health : Market and Competitor Analysis

Find stats on top websites

productops.com

www.projecthomes.org

Prognos Health is a healthcare technology company that provides a real-world data marketplace and analytics platform. They offer access to de-identified patient data, including laboratory results, medical claims, and genomic data, to support research, drug development, and commercialization efforts in the life sciences industry. Their platform enables clients to analyze patient journeys, identify potential drug targets, and optimize commercial strategies.

Company : Prognos Health

Industry : HealthcareLife SciencesReal-World Data

Major Markets

United States

Germany

United Kingdom

Key Competitors

IQVIA

Syneos Health

Parexel

Prognos Health Key Value propositions

Real-World Data

Data Analytics

Life Sciences Solutions

Healthcare Insights

Prognos Health Latest news

Prognos Health: Real-World Health Data Marketplace

Unlock the power of data to improve health with access to the most extensive and versatile managed real-world data marketplace solution available today.

Prognos Health | LinkedIn

Jun 4, 2023 ... About us ; Website: https://www.prognoshealth.com/. External link for Prognos Health ; Industry: Pharmaceutical Manufacturing ; Company size: 51- ...

News

Prognos Health and Invitae Partner to Improve Diagnosis and Advance Novel Treatments for Rare, Genetic-Driven Disease. March 13, 2024. Press Release. NEW YORK, ...

Prognos Health Announces Patent-Pending Technology

Apr 6, 2021 ... For more information, visit prognoshealth.com. For more about FACTOR Logic read the white paper. SOURCE Prognos Health. Related Links. http:// ...

Prognos Health SWOT Analysis

Strengths

Unique access to real-world patient dataAdvanced analytics platform for insightsStrong partnerships in healthcare

Weaknesses

Relatively new player in a competitive marketDependence on data partnershipsPotential data privacy concerns

Opportunities

Expansion into new therapeutic areasDevelopment of AI-driven solutionsStrategic partnerships with payers and providers

Threats

Competition from established data providersEvolving data privacy regulationsChanges in healthcare data sharing policies

Top Marketing Strategies for Prognos Health

Content Marketing & Thought Leadership

Establish Prognos Health as a thought leader in the RWD space by creating valuable content for target audiences like white papers, case studies, and webinars. This will build trust and credibility, attracting potential customers and positioning Prognos as a leading provider of RWD solutions.

Strategic Partnerships & Integrations

Collaborate with key players in the life sciences ecosystem, such as pharmaceutical companies, research institutions, and data providers, to integrate Prognos' platform with their existing systems. This will expand reach, enhance data accessibility, and create new revenue streams through joint ventures.

Targeted Account-Based Marketing (ABM)

Develop personalized marketing campaigns focused on high-value accounts within the life sciences and pharmaceutical industries. This will nurture relationships with decision-makers, showcase Prognos' value proposition, and generate qualified leads with a higher conversion rate.

Apply these strategies to your business with just one-click at Waxwing.ai

Prognos Health User Persona

Name:

Dr. Emily Carter

Age :

42

Gender :

Female

Occupation :

Senior Director of Clinical Development

Industry :

Pharmaceuticals

Education :

Ph.D., Molecular Biology

Preferred platforms

GOALS

To accelerate the development of a novel oncology drug by leveraging real-world data to identify potential trial participants and optimize patient recruitment
To improve the design of clinical trials by analyzing patient journeys and identifying key factors that influence treatment outcomes
To demonstrate the value of a new rare disease therapy to payers by providing data-driven insights into patient populations and treatment costs

Frustrations

Struggling to recruit a diverse and representative patient population for clinical trials, leading to delays and increased costs
Difficulty accessing and analyzing real-world data from disparate sources, hindering their ability to gain comprehensive insights
Facing challenges in communicating the value of new therapies to payers, who demand robust evidence of efficacy and cost-effectiveness

Name:

Mark Johnson

Age :

35

Gender :

Male

Occupation :

Data Scientist

Industry :

Life Sciences

Education :

Master's degree, Data Science

Preferred platforms

GOALS

To develop predictive models using real-world data to identify patients at high risk of developing a specific disease
To analyze patient data to understand the factors driving treatment decisions and identify opportunities for intervention
To create data-driven visualizations and reports that effectively communicate insights to stakeholders and inform strategic decision-making

Frustrations

Dealing with incomplete or inconsistent data, which requires significant time and effort to clean and prepare for analysis
Facing challenges in integrating data from different sources with varying formats and structures
Finding it difficult to keep up with the latest advancements in data science and machine learning techniques relevant to the healthcare industry

Name:

Sarah Williams

Age :

28

Gender :

Female

Occupation :

Market Research Analyst

Industry :

Biopharmaceuticals

Education :

Bachelor's degree, Business Administration

Preferred platforms

GOALS

To identify and segment target patient populations for a new drug launch, using real-world data to inform marketing strategies
To track the performance of marketing campaigns and measure their impact on patient outcomes
To stay abreast of emerging trends and competitive intelligence in the pharmaceutical market

Frustrations

Finding it challenging to access accurate and reliable real-world data on patient demographics, treatment patterns, and market dynamics
Struggling to measure the return on investment (ROI) of marketing campaigns due to limitations in tracking patient-level data
Facing difficulties in keeping up with the rapidly evolving regulatory landscape and its impact on pharmaceutical marketing practices

Prognos Health Geographic and Demographic Insights

Geographic Insights: Prognos Health's primary market is the US, followed by Germany and the UK. Japan and Canada hold significant but smaller market shares.

Top Countries

United States
60%
Germany
15%
United Kingdom
10%
Japan
7.5%
Canada
7.5%

Demographic Insights: Prognos Health's target audience is primarily professionals aged 35-54, with a slight skew towards males. This aligns with decision-making roles in life sciences.

Age Distribution

Gender Distribution

Prognos Health Socio-economic Profile

Household and Income Insights: Prognos Health's target users typically belong to households of 2-4 people and fall within the medium to high income brackets.

Educational and Employment Insights: Prognos Health's users are highly educated, with the majority holding postgraduate degrees and engaged in full-time employment.

Households Size

Income Distribution

Education Level

Employment Status

Prognos Health Behavioral Insights

Interest-Based Insights: Target users show strong interest in data science, AI, machine learning, healthcare tech, business intelligence, and pharmaceuticals.

Technology and Social Media Usage: Users primarily leverage LinkedIn, followed by Twitter and YouTube. They favor desktop devices for accessing information.

Interests

Data ScienceArtificial IntelligenceMachine LearningHealthcare TechnologyBusiness IntelligencePharmaceuticalsBiopharmaceuticals

Device Breakdown

Social Media Usage

Prognos Health Top Competitors

Competitor	Estimated market share	Top domains
IQVIA	40%	Real-World Data, Clinical Research, Healthcare Analytics
Syneos Health	30%	Clinical Trials, Commercialization, Patient Engagement
Parexel	15%	Drug Development, Regulatory Affairs, Clinical Research Services

productops.com

www.projecthomes.org

[email protected]